HealthQuill Phase 3 trial
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the US-based company.
Drugs Pharma

Johnson & Johnson ends late-stage trial of depression drug aticaprant

HQ Team March 7, 2025: Johnson & Johnson is discontinuing the Phase 3 VENTURA clinical trial of its experimental depression drug aticaprant after.

Read More
Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to treat a form of hypertension, according to a company statement.
Drugs Health Pharma

J&J halts final phase of trials of a drug to treat hypertension, says “futile” 

HQ Team September 7, 2023: Johnson & Johnson has decided to halt an experimental trial, in its final stages, on a drug to.

Read More